Clinical Trial Update: Study Of Generalized Anxiety Disorder [Phase 2]

View source ↗

Summary

This document reports a completed Phase 2 clinical trial sponsored by GlaxoSmithKline evaluating an investigational compound for generalized anxiety disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Investigational compound for generalized anxiety disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anxiety Disorder, Anxiety Disorders | Phase 2 | Status: COMPLETED